Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US6667024

Title:Alpha or beta emitters attached to fragments in radioimmunotherapy
Inventors:Goldenberg, David M.; Mendham, NJ, USA
Behr, Thomas M.; Goettingen, Germany
Summary:Described herein is a kit for radioimmunotherapy, comprising radioimmunoconjugates, methods and uses thereof. The invention relates to radioimmunoconjugates comprised of an alpha- or beta-emitting radioisotope and a binding site linked to or on an antigen-binding fragment of an antibody which specifically binds to a tumor-associated antigen. Therapeutic applications include targeted radioimmunotherapy such as in the treatment of tumors, as well as the administration of one or more clearing agents to a patient in conjunction with the radioimmunoconjugates along with the subsequent grafting of bone-marrow or autologous stem-cells.
Abstract:The present invention relates to radioimmunoconjugates useful in targeted radioimmunotherapy and methods of treating a patient using radioimmunoconjugates. The radioimmunoconjugates of the present invention comprise an alpha- or beta-emitting radioisotope and a binding site linked to or on an antigen-binding fragment of an antibody which specifically binds to a tumor-associated antigen. The methods of treating a patient can include administering one or more clearing agents to the patient in conjunction with the radioimmunoconjugate of the present invention, as well as subsequently grafting bone-marrow or autologous stem-cells to the patient.
US Patent Website:Click Here for Full Text of Patent
Title Number:US6667024
Application Number:US2000000588565
Date Filed:07/06/2000
Date Published:23/12/2003
Assignee:Center for Molecular Medicine and Immunology, Belleville, NJ, USA


 
Copyright © 2007 The Institute for Cellular Medicine  6/22/2021